Literature DB >> 17622605

Relevance of cost-effectiveness analysis to clinicians and policy makers.

Allan S Detsky1, Andreas Laupacis.   

Abstract

Mesh：

Year:  2007        PMID： 17622605     DOI： 10.1001/jama.298.2.221

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  23 in total

1.  Common Drug Review recommendations: an evidence base for expectations?

Authors:  Angela Rocchi; Elizabeth Miller; Robert B Hopkins; Ron Goeree
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

2.  A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processes.

Authors:  Gianluca Baio; Pierluigi Russo
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation.

Authors:  Christopher J D Wallis; Allan S Detsky
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

4.  The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the tailored activity program.

Authors:  Laura N Gitlin; Nancy Hodgson; Eric Jutkowitz; Laura Pizzi
Journal:  Am J Geriatr Psychiatry       Date:  2010-06       Impact factor: 4.105

5.  Cost-effectiveness of cataract surgery in Japan.

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2011-06-22       Impact factor: 2.447

Review 6.  The role of bortezomib, thalidomide and lenalidomide in the management of multiple myeloma: an overview of clinical and economic information.

Authors:  Andrea Messori; Dario Maratea; Chiara Nozzoli; Alberto Bosi
Journal:  Pharmacoeconomics       Date:  2011-04       Impact factor: 4.981

7.  Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study.

Authors:  Yoshimune Hiratsuka; Masakazu Yamada; Yoko Akune; Akira Murakami; Annabelle A Okada; Hidetoshi Yamashita; Yuichi Ohashi; Naoya Yamagishi; Hiroshi Tamura; Shunichi Fukuhara; Tomoyuki Takura
Journal:  Jpn J Ophthalmol       Date:  2013-04-16       Impact factor: 2.447

8.  Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis.

Authors:  Vicente Escudero-Vilaplana; Concepción Martínez-Nieto; Juan Manuel López-Gómez; Almudena Vega-Martínez; José María Bellón-Cano; María Sanjurjo-Sáez
Journal:  Int J Clin Pharm       Date:  2013-04-18

9.  A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil.

Authors:  Mirhelen Mendes de Abreu; David R Walker; Ricardo C Sesso; Marcos B Ferraz
Journal:  Perit Dial Int       Date:  2012-12-03       Impact factor: 1.756

Review 10.  Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: An Economic Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.